Steroid-Toxicity in Children: The Case for a Pediatric GTI
An estimated 10% of children will receive steroids during their childhood. For many, the treatment is life-saving. For far too many, steroids leave a trail of growth inhibition, delayed puberty, mood ...
Steroid-Toxicity in Pediatric Lupus: The Case for Standardized Measurement
Children with lupus carry a heavy steroid-toxicity burden that cannot be captured by measuring dose. A real-world study from Boston Children's Hospital and the Children's Hospital of Philadelphia ...
The Steritas pGTI: A Critical Tool for Pediatric Lupus Management
A new study led by Joyce Chang, MD MSCE from Boston Children's Hospital and Harvard Medical School, along with researchers from the Children's Hospital of Philadelphia, has underscored the pressing ...
Reshaping the Steroid Paradox
During 2023, the Steritas team had the opportunity to speak with a range of inspiring clinical research leaders who shared their expertise with us and our colleagues. Every conversation underscored ...
Surge in Adoption of the Steritas eCOA Suite Continues
Ever since the introduction of the Steritas Glucocorticoid Toxicity Index (GTI) in 2017, there has been a remarkable surge in the number of clinicians and clinical researchers using Steritas's ...
Curious about the true cost of steroid-toxicity?
Download our infographic today
